The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer: Efficacy and safety results of a randomized, phase III trial.
 
Zhongsheng Tong
No Relationships to Disclose
 
Shufen Li
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Xu Wang
No Relationships to Disclose
 
Chen Wang
No Relationships to Disclose
 
Chunfang Hao
No Relationships to Disclose
 
Xiaorui Wang
No Relationships to Disclose
 
Wenjin Meng
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose